Applicability of the EFSA Opinion on site‐directed nucleases type 3 for the safety assessment of plants developed using site‐directed nucleases type 1 and 2 and oligonucleotide‐directed mutagenesis
EFSA Panel on Genetically Modified Organisms (EFSA GMO Panel), Hanspeter Naegeli, Jean‐Louis Bresson, Tamas Dalmay, Ian Crawford Dewhurst, M. Epstein, Leslie George Firbank, Philippe Guerche, Jan Hejátko, F. Javier Moreno, Ewen Mullins, Fabien Nogué, Jose Juan Sánchez Serrano, G. Savoini, Eve Veromann, F. Veronesi, Josep Casacuberta, Andrea Gennaro, Konstantinos Paraskevopoulos, Tommaso Raffaello, Nils Rostoks
Abstract
are sufficient but are only partially applicable to plants generated via SDN-1, SDN-2 or ODM. Indeed, those guidance documents' requirements that are linked to the presence of exogenous DNA are not relevant for the risk assessment of plants developed via SDN-1, SDN-2 or ODM approaches if the genome of the final product does not contain exogenous DNA.